Comparative risk of acute kidney injury among cancer patients treated with immune checkpoint inhibitors

With the development and introduction of immune checkpoint inhibitors (ICIs) in cancer patients, immune‐related side effects have increasingly attracted attention. However, the risks of immune‐related renal toxicity are poorly characterized. In this study, we performed a network meta‐analysis (NMA)...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Fei, Wang, Zixian, Li, Xiaofan, Zhang, Zhen, Yang, Yue, Chen, Junquan, Chen, Dinghua, Wu, Lingling, Liu, Xiangyu, Han, Sujun, Wang, Fangming, Wahafu, Wasilijiang, Gao, Yibo, Ren, Shancheng, Xing, Nianzeng, Cai, Guangyan, Chen, Xiangmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9926960/
https://www.ncbi.nlm.nih.gov/pubmed/36528491
http://dx.doi.org/10.1002/cac2.12396

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9926960/
https://www.ncbi.nlm.nih.gov/pubmed/36528491
http://dx.doi.org/10.1002/cac2.12396

Ejemplares similares